Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment

Liver cancer is the second leading cause of cancer‐related deaths, and hepatocellular carcinoma (HCC) is the most common type. Therefore, molecular targets are urgently required for the early detection of HCC and the development of novel therapeutic approaches. Glypican‐3 (GPC3), an oncofetal proteo...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Medicinal research reviews Ročník 38; číslo 2; s. 741 - 767
Hlavní autoři:	Zhou, Fubo, Shang, Wenting, Yu, Xiaoling, Tian, Jie
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Wiley Subscription Services, Inc 01.03.2018
Témata:	Biomarkers, Tumor - metabolism Carcinoma, Hepatocellular - blood Carcinoma, Hepatocellular - diagnosis Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - therapy Disease Progression Glypicans - blood Glypicans - chemistry Glypicans - metabolism glypican‐3 hepatocellular carcinoma Humans Liver cancer Liver Neoplasms - blood Liver Neoplasms - diagnosis Liver Neoplasms - pathology Liver Neoplasms - therapy Medical imaging Molecular Targeted Therapy glypican-3 hepatocellular carcinoma
ISSN:	0198-6325, 1098-1128, 1098-1128
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!